Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Abacavir Induces Arterial Thrombosis in a Murine Model.

Collado-Diaz V, Andujar I, Sanchez-Lopez A, Orden S, Blanch-Ruiz MA, Martinez-Cuesta MA, Blas-García A, Esplugues JV, Álvarez Á.

J Infect Dis. 2018 Jun 20;218(2):228-233. doi: 10.1093/infdis/jiy001.

PMID:
29346575
2.

Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation.

Alvarez A, Orden S, Andújar I, Collado-Diaz V, Núñez-Delgado S, Galindo MJ, Estrada V, Apostolova N, Esplugues JV.

AIDS. 2017 Aug 24;31(13):1781-1795. doi: 10.1097/QAD.0000000000001547. Review.

PMID:
28537935
3.

Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis.

Alvarez A, Rios-Navarro C, Blanch-Ruiz MA, Collado-Diaz V, Andujar I, Martinez-Cuesta MA, Orden S, Esplugues JV.

Antiviral Res. 2017 May;141:179-185. doi: 10.1016/j.antiviral.2017.03.001. Epub 2017 Mar 2.

PMID:
28263802
4.

Interference with purinergic signalling: an explanation for the cardiovascular effect of abacavir?

Esplugues JV, De Pablo C, Collado-Díaz V, Hernández C, Orden S, Álvarez Á.

AIDS. 2016 Jun 1;30(9):1341-51. doi: 10.1097/QAD.0000000000001088.

PMID:
26990628
5.

Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions.

Ríos-Navarro C, de Pablo C, Collado-Diaz V, Orden S, Blas-Garcia A, Martínez-Cuesta MÁ, Esplugues JV, Alvarez A.

Eur J Pharmacol. 2015 Oct 15;765:355-65. doi: 10.1016/j.ejphar.2015.08.054. Epub 2015 Sep 4.

Supplemental Content

Loading ...
Support Center